Literature DB >> 20116809

Spectrum of epilepsy in Wilson's disease with electroencephalographic, MR imaging and pathological correlates.

L K Prashanth1, S Sinha, A B Taly, M K Vasudev, S K Shankar.   

Abstract

BACKGROUND: Seizures are uncommon in Wilson's disease.
OBJECTIVE: To analyze profile of seizures in WD and to correlate with EEG and MR imaging observations. SUBJECTS AND METHODS: 41/490 patients (8.3%) of WD were documented to have seizures. Autopsy observations were available in 3 cases.
RESULTS: The age at onset of seizures was 12.8+/-5.7years. Seizure - preceded the onset of characteristic features of WD (19.5%); occurred concurrently (46.3%); or, followed de-coppering therapy (29.2%) and occurred as terminal event (4.8%). The types of seizures were: generalized tonic-clonic - 29, simple partial - 8, complex partial - 6, partial seizures with secondary generalization - 2 and periodic myoclonus - 1. Six patients had multiple seizure types and 4 had status epilepticus. EEG abnormalities were frequent (19/24) consisting of background slowing and epileptiform discharges. MRI (n=20) revealed varying degree of atrophy and signal changes involving basal ganglia, brainstem and white matter. The duration of follow-up was 8.1+/-9.2years. The outcome of seizure was: no recurrence - 68.3%, breakthrough seizures - 17.1%, poor control - 9.7% and no follow-up - 4.9%. Two of them succumbed following cluster attacks. Autopsy revealed cavitatory lesions in white matter in frontal, temporal and parietal areas with varying involvement of cortical ribbon. Patients with seizures had more often white matter changes than those without. It was also noted that patients whose seizures were not controlled had MRI suggestive of cavitation of white matter, though the reverse was not true.
CONCLUSIONS: This is the largest series regarding epilepsy in WD. Seizures are not uncommon and could occur at any stage. Deafferentation of white matter tracts from cortex may contribute for seizure in WD. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20116809     DOI: 10.1016/j.jns.2010.01.007

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  18 in total

Review 1.  Challenges in the diagnosis of Wilson disease.

Authors:  Aurélia Poujois; France Woimant
Journal:  Ann Transl Med       Date:  2019-04

Review 2.  Neurologic impairment in Wilson disease.

Authors:  Petr Dusek; Tomasz Litwin; Anna Członkowska
Journal:  Ann Transl Med       Date:  2019-04

Review 3.  Decompensated Liver Disease in a Patient with Neurocysticercosis.

Authors:  Sarah Safadi; Aly M Mohamed; Barakat A Altamimi; Robert G Strickland; Denis M McCarthy
Journal:  Dig Dis Sci       Date:  2017-06       Impact factor: 3.199

Review 4.  Wilson disease.

Authors:  Anna Członkowska; Tomasz Litwin; Petr Dusek; Peter Ferenci; Svetlana Lutsenko; Valentina Medici; Janusz K Rybakowski; Karl Heinz Weiss; Michael L Schilsky
Journal:  Nat Rev Dis Primers       Date:  2018-09-06       Impact factor: 52.329

5.  Atypical neuroimaging in Wilson's disease.

Authors:  Rushad Patell; Rupal Dosi; Harshal K Joshi; Dennis Storz
Journal:  BMJ Case Rep       Date:  2014-06-06

6.  Diffusion tensor imaging (DTI) and its clinical correlates in drug naïve Wilson's disease.

Authors:  Rakesh Jadav; Jitender Saini; Sanjib Sinha; Bhavanishankara Bagepally; S Rao; Arun B Taly
Journal:  Metab Brain Dis       Date:  2013-05-01       Impact factor: 3.584

Review 7.  The Pragmatic Treatment of Wilson's Disease.

Authors:  Annu Aggarwal; Mohit Bhatt
Journal:  Mov Disord Clin Pract       Date:  2014-04-10

8.  Evaluation of candidate genes from orphan FEB and GEFS+ loci by analysis of human brain gene expression atlases.

Authors:  Rosario M Piro; Ivan Molineris; Ugo Ala; Ferdinando Di Cunto
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

Review 9.  Inherited copper transport disorders: biochemical mechanisms, diagnosis, and treatment.

Authors:  Hiroko Kodama; Chie Fujisawa; Wattanaporn Bhadhprasit
Journal:  Curr Drug Metab       Date:  2012-03       Impact factor: 3.731

Review 10.  Myoclonic Disorders.

Authors:  Olaf Eberhardt; Helge Topka
Journal:  Brain Sci       Date:  2017-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.